Medscape9d
The Use of Nesiritide in the Management of Acute Decompensated Heart Failure
Although numerous intravenous agents are available for the treatment of acute decompensated heart failure, there are no current guidelines to help optimize treatment strategies for hospitalized ...
ahajournals.org4d
Hospital Variability in the Use of Vasoactive Agents in Patients Hospitalized for Acute Decompensated Heart Failure for Clinical Phenotypes
The absence of practice standards in vasoactive agent usage for acute decompensated heart failure has resulted in significant treatment variability across hospitals, potentially affecting patient ...
Medscape6d
Nesiritide in Infants and Children With Congestive Heart Failure
Objectives: Nesiritide (synthetic B-type natriuretic peptide) has been shown to be effective in the management of acute decompensated heart failure in adults. The role of nesiritide in pediatric ...
openheart.bmj26d
Acute kidney injury recovery status predicts mortality and cardiorenal outcomes in patients admitted with acute decompensated heart failure
Background Acute kidney injury (AKI) in the context of acute decompensated heart failure (ADHF) encompasses a broad spectrum of phenotypes with associated disparate outcomes. We evaluate the impact of ...
Frontiers18d
Impact of comorbid constipation on the survival of patients with heart failure: a multicenter, prospective cohort study conducted in Japan
We examined the effect of comorbid constipation on the survival of patients with heart failure. Methods: We conducted a multicenter prospective cohort study (the Kochi YOSACOI study) of patients ...
Frontiers18d
Comparative efficacy of different drugs in acute heart failure with renal dysfunction: a systematic review and network meta-analysis
MeSH terms included keywords, including “acute heart failure”, “acute decompensated heart failure”, “heart failure”, and recommended drugs: diuretics, vasopressin V2 receptor antagonists, ACEI, ARBs, ...